| Jessica Kienast, PHARMD | |
|
377 N Rolling Meadows Dr, Fond Du Lac, WI 54937-9726 | |
| (920) 921-9591 | |
| Not Available |
| Full Name | Jessica Kienast |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 377 N Rolling Meadows Dr, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215536669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15906-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Kienast, PHARMD 377 N Rolling Meadows Dr, Fond Du Lac, WI 54937-9726 Ph: (920) 921-9591 | Jessica Kienast, PHARMD 377 N Rolling Meadows Dr, Fond Du Lac, WI 54937-9726 Ph: (920) 921-9591 |
News Archive
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an exclusive agreement to leverage the translational research expertise of Dr. Jason Chesney, Associate Professor, Department of Medicine at the University of Louisville's James Graham Brown Cancer Center (Brown Cancer Center), to identify new clinical candidates for the prevention and treatment of cancers against two key cancer metabolic targets.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The U.S. Food and Drug Administration has expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years.
Children with severe to profound hearing loss under evaluation for cochlear implantation have traditionally been given a three to six month hearing aid trial to verify that they don't receive sufficient audiometric and speech benefit from hearing aids before proceeding with cochlear implantation.
› Verified 5 days ago
Charles Allen Gorske, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 485 N Rolling Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-921-6759 Fax: 920-921-6759 | |
Mrs. Michelle M Cunningham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 192 N Main St, Walgreens Pharmacy, Fond Du Lac, WI 54935 Phone: 920-922-9634 Fax: 920-921-2760 | |
John M Driedric, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 616 W Johnson St, Fond Du Lac, WI 54935 Phone: 920-921-5490 | |
Maris Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 420 E Division St, Pharmacy Plus, Fond Du Lac, WI 54935 Phone: 920-926-8585 Fax: 920-926-8935 | |
Rhett R Koski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 W Pioneer Rd, Fond Du Lac, WI 54935 Phone: 920-907-0556 Fax: 920-907-0639 | |
Tou Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1060 E Johnson St, Fond Du Lac, WI 54935 Phone: 920-266-4323 | |
Ms. Lori Sue Pachefsky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 192 N Main St, Fond Du Lac, WI 54935 Phone: 920-921-5264 Fax: 920-921-2760 |